Article info

Protocol
Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial

Authors

  1. Correspondence to Laura Janssen; laura.janssen{at}maastrichtuniversity.nl
View Full Text

Citation

Janssen L, Romberg-Camps M, van Bodegraven A, et al
Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial

Publication history

  • Received July 17, 2020
  • Revised December 15, 2020
  • Accepted April 11, 2021
  • First published May 4, 2021.
Online issue publication 
May 04, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.